AngioDynamics, Inc. vs. Stryker Corporation
Stryker Corporation (SYK) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| ANGO | SYK | |
|---|---|---|
| Market Cap | $635.28 million | $107.45 billion |
| Revenue (TTM) | $320.17 million | $25.84 billion |
| Net Income (TTM) | $-36,742,000 | $3.73 billion |
SYK leads on 3 of 3 size & scale factors.
Valuation
| ANGO | SYK | |
|---|---|---|
| P/E Ratio | — | 28.68 |
| Price / Book | 3.72 | 4.48 |
| Price / Sales | 1.98 | 4.16 |
ANGO leads on 2 of 2 valuation factors.
Profitability
| ANGO | SYK | |
|---|---|---|
| Net Margin | -11.48% | 14.43% |
| Return on Equity | -21.51% | 15.55% |
SYK leads on 2 of 2 profitability factors.
Dividend
| ANGO | SYK | |
|---|---|---|
| Dividend Yield | — | 1.27% |
| Payout Ratio | — | 36.48 |
ANGO and SYK split the dividend factors evenly.
Risk & Sentiment
| ANGO | SYK | |
|---|---|---|
| Short Interest | 4.46% | 1.53% |
SYK leads on 1 of 1 risk & sentiment factors.
Dig deeper: ANGO overview, ANGO financials, SYK overview, SYK financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.